Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy in Head and Neck Cancer: Where Do We Stand?
Natalia G. Vallianou, Angelos Evangelopoulos, Dimitris Kounatidis, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 8, pp. 897-912
Closed Access | Times Cited: 17

Showing 17 citing articles:

Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle
Marco Cordani, Raffaele Strippoli, Flavia Trionfetti, et al.
Cancer Letters (2024) Vol. 585, pp. 216661-216661
Open Access | Times Cited: 5
State of the Art Therapy for Recurrent or Advanced Head and Neck Cancer
Koosha Paydary, Nikhil Joshi, Michael J. Jelinek
Advances in Oncology (2025)
Closed Access
Releasing the brakes: the role of immune checkpoint inhibitors in laryngeal cancer
Michail Athanasopoulos, Pinelopi Samara, George Agrogiannis, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Pretreatment Circulating HPV16 DNA Viral Load Predicts Risk of Distant Metastasis in Patients with HPV16-Positive Oropharyngeal Cancer
Agnieszka Mazurek, Iwona Jabłońska, Marek Kentnowski, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1163-1163
Open Access | Times Cited: 3
Advances in human papillomavirus detection and molecular understanding in head and neck cancers: Implications for clinical management
Ngoc Ha Tran, Dayna Sais, Nham Tran
Journal of Medical Virology (2024) Vol. 96, Iss. 6
Open Access | Times Cited: 3
Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer
Lisa A. Santry, Jacob P. van Vloten, Amanda W.K. AuYeung, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models
Justin Yu, Jacob Gadwa, Richard B. Ross, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 2
Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma
Ping Yang, Guangzhao Huang, Yulin Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)
Arif Akyıldız, Deniz Can Güven, Barış Köksal, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 9, pp. 4991-4999
Open Access | Times Cited: 2
Clinical metabolomics: useful insights, perspectives and challenges
Μaria Dalamaga
Metabolism Open (2024) Vol. 22, pp. 100290-100290
Open Access | Times Cited: 2
Durvalumab with or without tremelimumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis
Xiao Han, Haidong Zhang, Kai Sun, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 1
Effects of Vitamin D on tumor cell proliferation and migration, tumor initiation and anti-tumor immune response in head and neck squamous cell carcinomas
Lukas Brust, Maximilian Linxweiler, Jana Schnatmann, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117497-117497
Open Access | Times Cited: 1
Integrating immune multi-omics and machine learning to improve prognosis, immune landscape, and sensitivity to first- and second-line treatments for head and neck squamous cell carcinoma
Yin Ji, Lin Xu, Shange Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Recent advances in head and neck surgical oncology
Amit Ritter, Helena Levyn, Jatin P. Shah
Journal of Surgical Oncology (2023) Vol. 129, Iss. 1, pp. 32-39
Closed Access | Times Cited: 4
Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer
Jenna Bouassaly, Naser Mohamad Karimi, Luiz Paulo Kowalski, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104326-104326
Closed Access
Integrating Immune Multi-Omics and Machine Learning to Improve Prognosis, Immune Landscape, and Sensitivity to First- and Second-Line Treatments for Head and Neck Squamous Cell Carcinoma
Yin Ji, Lin Xu, Shange Wang, et al.
Research Square (Research Square) (2024)
Open Access
Tumor Microenvironment Role in Cancer Immunotherapy Response
Jamerson Carvalho Silva, Flávia Caló de Aquino Xavier, Manoela Carrera
Interdisciplinary cancer research (2024)
Closed Access
Page 1

Scroll to top